Please use this identifier to cite or link to this item:
http://hdl.handle.net/10637/9746
Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.
Title: | Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. |
Authors : | Pastor, Myriam Fernández Calle, Rosalía Di Geronimo Quintero, Bruno Vicente Rodríguez, Marta Zapico Rodríguez, José María Gramage Caro, Esther Coderch Boué, Claire Pérez García, Carmen Lasek, Amy W. Puchades-Carrasco, Leonor Pineda-Lucena, Antonio Pascual-Teresa Fernández, Beatriz de Herradón Gil-Gallardo, Gonzalo Ramos González, Ana |
Keywords: | PTPRZ1inhibitors; Pleiotrophin; Neurogenerative diseases |
Publisher: | Elsevier |
Citation: | Pastor M, Fernández-Calle R, Di Geronimo B, Vicente-Rodríguez M, Zapico JM, Gramage E, et al. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. Vol. 144, European Journal of Medicinal Chemistry. 2018. p. 318-29 |
URI: | http://hdl.handle.net/10637/9746 |
Rights : | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
ISSN: | 0223-5234 |
Issue Date: | 20-Jan-2018 |
Center : | Universidad San Pablo-CEU |
Appears in Collections: | Facultad de Farmacia |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.